Sangamo Therapeutics Statistics
Total Valuation
SGMO has a market cap or net worth of $164.31 million. The enterprise value is $147.86 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SGMO has 301.71 million shares outstanding. The number of shares has increased by 20.61% in one year.
| Current Share Class | 301.71M |
| Shares Outstanding | 301.71M |
| Shares Change (YoY) | +20.61% |
| Shares Change (QoQ) | +16.65% |
| Owned by Insiders (%) | 1.10% |
| Owned by Institutions (%) | 17.05% |
| Float | 295.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.48 |
| Forward PS | 1.78 |
| PB Ratio | 7.51 |
| P/TBV Ratio | 8.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.81 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 1.20.
| Current Ratio | 1.05 |
| Quick Ratio | 0.91 |
| Debt / Equity | 1.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -17.19 |
Financial Efficiency
Return on equity (ROE) is -292.47% and return on invested capital (ROIC) is -81.82%.
| Return on Equity (ROE) | -292.47% |
| Return on Assets (ROA) | -41.15% |
| Return on Invested Capital (ROIC) | -81.82% |
| Return on Capital Employed (ROCE) | -125.74% |
| Revenue Per Employee | $446,481 |
| Profits Per Employee | -$345,940 |
| Employee Count | 183 |
| Asset Turnover | 0.86 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -193,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.39% in the last 52 weeks. The beta is 1.19, so SGMO's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -36.39% |
| 50-Day Moving Average | 0.53 |
| 200-Day Moving Average | 0.99 |
| Relative Strength Index (RSI) | 50.12 |
| Average Volume (20 Days) | 5,762,671 |
Short Selling Information
The latest short interest is 15.96 million, so 5.29% of the outstanding shares have been sold short.
| Short Interest | 15.96M |
| Short Previous Month | 13.66M |
| Short % of Shares Out | 5.29% |
| Short % of Float | 5.41% |
| Short Ratio (days to cover) | 2.21 |
Income Statement
In the last 12 months, SGMO had revenue of $81.71 million and -$63.31 million in losses. Loss per share was -$0.28.
| Revenue | 81.71M |
| Gross Profit | -22.79M |
| Operating Income | -62.74M |
| Pretax Income | -248.51M |
| Net Income | -63.31M |
| EBITDA | -58.27M |
| EBIT | -62.74M |
| Loss Per Share | -$0.28 |
Full Income StatementBalance Sheet
The company has $38.34 million in cash and $23.46 million in debt, giving a net cash position of $14.88 million or $0.05 per share.
| Cash & Cash Equivalents | 38.34M |
| Total Debt | 23.46M |
| Net Cash | 14.88M |
| Net Cash Per Share | $0.05 |
| Equity (Book Value) | 19.60M |
| Book Value Per Share | 0.07 |
| Working Capital | 2.23M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$35.90 million and capital expenditures -$291,000, giving a free cash flow of -$36.19 million.
| Operating Cash Flow | -35.90M |
| Capital Expenditures | -291,000 |
| Free Cash Flow | -36.19M |
| FCF Per Share | -$0.12 |
Full Cash Flow StatementMargins
Gross margin is -27.89%, with operating and profit margins of -76.79% and -77.48%.
| Gross Margin | -27.89% |
| Operating Margin | -76.79% |
| Pretax Margin | -77.72% |
| Profit Margin | -77.48% |
| EBITDA Margin | -71.32% |
| EBIT Margin | -76.79% |
| FCF Margin | n/a |
Dividends & Yields
SGMO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.61% |
| Shareholder Yield | -20.61% |
| Earnings Yield | -38.90% |
| FCF Yield | -22.24% |
Analyst Forecast
The average price target for SGMO is $4.50, which is 726.30% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.50 |
| Price Target Difference | 726.30% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 40.14% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SGMO has an Altman Z-Score of -21.84 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -21.84 |
| Piotroski F-Score | 4 |
